Showing results (61-70 of 110) with videos related to

Sort By:
Pageof 11
Journal of the American Academy of Audiology|January 9, 2018
A Randomized Controlled Trial to Evaluate Approaches to Auditory Rehabilitation for Blast-Exposed Veterans with Normal or Near-Normal Hearing Who Report Hearing Problems in Difficult Listening SituationsGabrielle H Saunders, Melissa T Frederick, Michelle L Arnold, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 9, 2007
Successful combination therapy of a proximal haemophilic pseudotumour with surgery, radiation and embolization in a child with mild haemophilia AS P Ahuja, R Sidonio, A B Raj, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Kampanols: novel Ras farnesyl-protein transferase inhibitors from Stachybotrys kampalensisS B Singh, D L Zink, M Williams, et al.
Health Affairs (Project Hope)|October 3, 2022
Excluding People With Disabilities From Clinical Research: Eligibility Criteria Lack Clarity And JustificationWillyanne DeCormier Plosky, Ari Ne'eman, Benjamin C Silverman, et al.
NPP - Digital Psychiatry and Neuroscience|April 8, 2026
Advancing neurotech justice in youth digital mental health: insights from an interdisciplinary and cross-generational workshopCraig W McFarland, Donnella S Comeau, Sepideh Abdi, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1991
Immunization of owl monkeys with a recombinant protein containing repeated epitopes of a Plasmodium falciparum glycophorin-binding proteinN E Aronson, C Silverman, G F Wasserman, et al.
Biochemical and Biophysical Research Communications|March 17, 1997
Oreganic acid, a potent inhibitor of ras farnesyl-protein transferaseK C Silverman, H Jayasuriya, C Cascales, et al.
Bioorganic & Medicinal Chemistry Letters|March 18, 2003
Four novel bis-(naphtho-gamma-pyrones) isolated from Fusarium species as inhibitors of HIV-1 integraseSheo B Singh, Deborah L Zink, Gerald F Bills, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Liposomal malaria vaccine in humans: a safe and potent adjuvant strategyL F Fries, D M Gordon, R L Richards, et al.
The American Journal of Tropical Medicine and Hygiene|November 1, 1994
Safety, immunogenicity, and efficacy of a malaria sporozoite vaccine administered with monophosphoryl lipid A, cell wall skeleton of mycobacteria, and squalane as adjuvantS L Hoffman, R Edelman, J P Bryan, et al.
Pageof 11